Crossmark

Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseases

Crossref DOI link: https://doi.org/10.1186/s13287-018-0986-y

Published Online: 2018-09-26

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Di Rocco, Giuliana

Baldari, Silvia

Gentile, Antonietta

Capogrossi, Maurizio

Toietta, Gabriele https://orcid.org/0000-0003-4182-2468
Funding

Funding for this research was provided by:

Ministero della Salute (RF-2011-02347907)

Istituto Regina Elena (5x1000 2014)
License Information

Text and Data Mining valid from 2018-09-26
More Information

Article History

Received: 4 June 2018

Revised: 14 August 2018

Accepted: 17 August 2018

First Online: 26 September 2018

Ethics approval

: The use of human tissues for this research was in compliance with the Helsinki Declaration and approved by the ethics committee of (University “La Sapienza” protocol identification n° 1794/15, 13/02/2015). Animal procedures and maintenance were performed according to the Guidelines of the National Institutes of Health (Art. 31 D.lgs 26/2014, 4 March 2014).

: Not applicable.

: The authors declare that they have no competing of interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.